These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1264407)

  • 1. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
    Southern EM; Gutknecht GD
    Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of prostaglandin E2 vaginal suppositories in intrauterine fetal death and missed abortion.
    Bailey CD; Newman C; Ellinas SP; Anderson GG
    Obstet Gynecol; 1975 Jan; 45(1):110-3. PubMed ID: 1110809
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Midtrimester pregnancy termination with prostaglandin E2 vaginal suppositories.
    Hochman M; Laufe LE
    J Reprod Med; 1976 May; 16(5):263-8. PubMed ID: 933105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
    Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
    Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intrauterine (extraamniotic) prostaglandins in the management of unsuccessful pregnancy.
    Calder AA; Mackenzie IZ; Embrey MP
    J Reprod Med; 1976 May; 16(5):271-5. PubMed ID: 933106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
    Kent DR; Goldstein AI; Linzey EM
    J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of prostaglandin E2 vaginal suppository in missed abortion, intrauterine death and hydatidiform mole.
    Takagi LR; Gulling EA; O'Leary JA
    J Med Assoc Ga; 1978 Aug; 67(8):644-5. PubMed ID: 574529
    [No Abstract]   [Full Text] [Related]  

  • 8. Termination of pregnancy in patients with missed abortion and intrauterine dead fetuses by a single intracervical application of prostaglandin E2 in viscous gel.
    Ekman G; Forman A; Ulmsten U; Wingerup L
    Zentralbl Gynakol; 1980; 102(4):219-22. PubMed ID: 7467962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaginal prostaglandin E2 for missed abortion and intrauterine fetal death.
    Rutland A; Ballard C
    Am J Obstet Gynecol; 1977 Jul; 128(5):503-6. PubMed ID: 879208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
    Thiery M; Amy JJ; Decoster JM
    Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostaglandin E2 induction of labor for fetal demise.
    Kent DR; Goldstein AI
    Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rare obstetric contraindication to the use of vaginal prostaglandins for fetal demise.
    Waszak SJ
    J Reprod Med; 1979 Apr; 22(4):204-6. PubMed ID: 458763
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
    Boehm FH; Killam AP; Chambers JF; Davidson KK
    Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Midtrimester abortion induced by serial intravaginal administration of prostaglandin E2 suppositories in conjunction with a contraceptive diaphragm.
    Lauersen NH; Wilson KH
    Prostaglandins; 1975 Jul; 10(1):139-50. PubMed ID: 1153798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of missed abortion, intrauterine death and hydatidiform mole using prostaglandin E2.
    Murray CP; Clinch J
    Ir Med J; 1975 Mar; 68(6):133-5. PubMed ID: 1120656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaginal prostaglandin E2 in the management of fetal intrauterine death.
    Southern EM; Gutknecht GD; Mohberg NR; Edelman DA
    Br J Obstet Gynaecol; 1978 Jun; 85(6):437-41. PubMed ID: 350261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
    Lauersen NH; Cederqvist LL; Wilson KH
    Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protocol for management of unsuccessful pregnancy.
    Hodgson JE; Ditmanson GM
    Minn Med; 1980 Feb; 63(2):134-8. PubMed ID: 7382975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of abortion by intra-amniotic administration of prostaglandin F2 alpha in patients with intrauterine fetal death and missed abortion.
    Antsaklis A; Diakomanolis E; Karayannopoulos C; Aravantinos D; Kaskarelis D
    Int Surg; 1979; 64(5):41-3. PubMed ID: 299443
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early midtrimester pregnancy termination. A comparison of dilatation and evacuation and intravaginal prostaglandin E2.
    Robins J; Surrago EJ
    J Reprod Med; 1982 Jul; 27(7):415-9. PubMed ID: 6956734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.